-
BTG INTERNATIONAL LIMITED et al v. AMNEAL PHARMACEUTICALS LLC,. et al DC CAFC
- 2:15-cv-05909
- D.N.J.
- Judge: Kevin McNulty
+1
- Filed: 07/31/2015
- Closed: 02/14/2022
- Latest Docket Entry: 05/24/2022
- PACER
4
Plaintiffs
28
Defendants
1
Accused
Product
2
Patents-in-Suit
2,391
Days in
Litigation
-
BTG INTERNATIONAL LIMITED et al v. AMNEAL PHARMACEUTICALS LLC,. et al DC CAFC
- 2:15-cv-05909
- D.N.J.
- Judge: Kevin McNulty
+1
- Filed: 07/31/2015
- Closed: 02/14/2022
- Latest Docket Entry: 05/24/2022
- PACER
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 4 |
The method of claim 3, wherein the therapeutically effective amount of the abiraterone acetate or pharmaceutically acceptable salt thereof is about 1000 mg/day.
|
Invalid
Entry 572 |
| 8 |
The method of claim 7, wherein the therapeutically effective amount of the prednisone is about 10 mg/day.
|
Invalid
Entry 572 |
| 11 |
The method of claim 10, comprising administering to said human about 1000 mg/day of abiraterone acetate or a pharmaceutically acceptable salt thereof and about 10 mg/day of prednisone.
|
Invalid
Entry 572 |
| 19 |
The method of claim 18, comprising administering to said human about 1000 mg/day of abiraterone acetate or a pharmaceutically acceptable salt thereof and about 10 mg/day of prednisone.
|
Invalid
Entry 572 |
| 20 |
The method of claim 17, comprising administering to said human about 1000 mg/day of abiraterone acetate or a pharmaceutically acceptable salt thereof and about 10 mg/day of prednisone.
|
Invalid
Entry 572 |
| All Claims |
NA
|
Enforceable and Valid
Entry 467 |
-
Infringement
Actavis Laboratories FL Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Amneal Pharmaceuticals, LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Apotex Corporation
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tabletsGeneric abirnterone acetate 500mg tablets, | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 467Entry 572 |
Apotex Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tabletsGeneric abirnterone acetate 500mg tablets, | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 467Entry 572 |
Citron Pharma llc
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Dr. Reddy's Laboratories, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Dr. Reddy's Laboratories Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Hetero Labs Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Hetero Labs Limited Unit V
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Hetero USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Hikma Pharmaceuticals LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Mylan Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone AcetateAbiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572Entry 607 |
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone AcetateAbiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572Entry 607 |
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Par Pharmaceutical, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Sun Pharmaceutical Industries, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Teva Pharmaceuticals USA, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
West-Ward Pharmaceutical Corporation
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Wockhardt Bio AG
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Wockhardt Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
Wockhardt USA LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Abiraterone acetate tablets | US 8,822,438 B2 |
4, 8, 11, 19, 20
|
Infringement
Entry 572
|
